The Chinese Pulmonary Lymphoepithelioma-like Carcinoma Collaboration Study
Recruiting
Observational Study
Primary Pulmonary Lymphoepithelioma-like Carcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10,000 (estimated)
- Sponsor
- Sun Yat-sen University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This retrospective case-control study aims to investigate the genetic mechanisms of primary Pulmonary Lymphoepithelioma-like Carcinoma, identify genetic susceptibility loci associated with its onset, and explore potential pathogenic genes, providing new insights for its etiological research.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Case:
Inclusion criteria:
The subject is pathologically diagnosed with primary pulmonary lymphoepithelioma-like carcinoma.
Exclusion criteria:
The subject is diagnosed with metastatic nasopharyngeal carcinoma; The subject has heavy cardiovascular, liver, or kidney disease.
Controls:
Inclusion …
Contacts